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ABSTRACT
Introduction Gender identity development services (GIDS) 
worldwide have seen a significant increase in referrals in 
recent years. Many of these referrals consist of children 
and young people (CYP) who experience gender- related 
distress. This study aims to improve understanding of 
outcomes of CYP referred to the UK GIDS, specifically 
regarding gender identity, mental health, physical health 
and quality of life. The impact of factors such as co- 
occurring autism and early social transition on outcomes 
over time will be explored.
Methods and analysis This is a prospective cohort study 
of CYP aged 3–14 years when referred to the UK GIDS. 
Eligible participants will be ≤14 years at the time their 
referral was accepted and will be on the waitlist for the 
service when baseline measures are completed. Children 
aged under 12 years will complete the measures in an 
interview format with a researcher, while young people 
aged 12 years and over and their parents/caregivers 
will complete online or paper- based questionnaires. 
Participants will complete follow- up measures 12 months 
and 24 months later. The final sample size is expected 
to be approximately 500. Logistic regression models will 
be used to explore associations between prespecified 
explanatory variables and gender dysphoria. Appropriate 
regression models will also be used to investigate 
explanatory variables for other outcomes. Subgroup 
analyses based on birth- assigned gender, age at referral 
and co- occurring autistic traits will be explored.
Ethics and dissemination The study has been approved 
by the Health Research Authority and London – Hampstead 
Research Ethics Committee (reference: 19/LO/0857). The 
study findings will be published in peer- reviewed journals 
and presented at both conferences and stakeholder 
events. Findings will be used to inform clinical practice.
INTRODUCTION
Gender identity development services 
(GIDS) for children and young people 
(CYP) have experienced a significant rise 
in referrals over recent years.1 2 In the UK 
GIDS, this is evidenced by an increase from 
1408 referrals of CYP in 2015/2016 to 2728 
referrals of CYP in 2019/2020.3 A changing 
pattern in referrals has also been observed, 
and in particular, there has been a shift to an 
increase in referrals of CYP assigned female at 
birth.4 5 It has been noted that CYP referred 
to the GIDS are a heterogeneous group, and 
while some report distress associated with a 
mismatch between their gender assigned at 
birth and their gender identity, others do 
not report such distress.6 Furthermore, some 
CYP who are referred to the service identify 
with a non- binary identity.6 7 Although these 
studies provide important insights into the 
characteristics of CYP who are referred to the 
GIDS, large- scale studies assessing outcomes 
over time for these CYP are lacking, and thus, 
Strengths and limitations of this study
 ► This study will recruit a large cohort from one of the 
world’s largest gender identity development ser-
vices (GIDS) for children and young people.
 ► The prospective longitudinal cohort study design 
will enable documentation of the natural history and 
outcomes over time of children and young people 
referred to the UK GIDS.
 ► Data will be collected directly from both children and 
young people and their parent/caregiver.
 ► As this is a 2- year prospective study, it will not be 
possible to ascertain longer term health and well- 
being outcomes and treatment decisions.
 ► As the study is recruiting families on the GIDS wait-
list, this is a potentially challenging population to 
access as they are not in receipt of clinical services 
at the time of recruitment.
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longitudinal research is needed to further inform clinical 
practice.
Findings from a number of studies indicate that CYP 
referred to gender services often experience mental 
health difficulties, such as depression and anxiety, with 
prevalence tending to increase with age.8–10 High rates of 
self- harm and suicidality are also common.10–12 Further-
more, co- occurring gender dysphoria and autism have 
been reported for some CYP who are referred to gender 
services.13 14 As co- occurring conditions are frequently 
reported for gender diverse CYP, it is important to explore 
the extent to which these impact longer term outcomes 
and to consider how clinical services can best support the 
needs of these CYP.
An increasing number of younger children who have 
already socially transitioned (ie, changed clothing, hair-
style, first name and pronouns to reflect their gender 
identity) at the time of referral to gender services has 
been reported.15 Recent research has suggested that 
this early social transition can have desirable outcomes 
for CYP, particularly in relation to a reduction in mental 
health difficulties.16 17 However, the longer term impacts 
of early social transition in childhood have not yet been 
determined.18 19 Thus, prospective longitudinal research 
is needed to investigate outcomes in relation to early 
social transition, particularly in prepubertal children.20
Current NHS intervention for CYP experiencing 
gender dysphoria is aimed at alleviating dysphoric feel-
ings, improving well- being and supporting CYP and their 
families to make informed decisions about treatment and 
the meaning of gender identity within their own lives and 
contexts.6 However, the evidence on which current treat-
ment protocols are based is widely acknowledged to be 
limited, and predictors of individual gender and psycho-
sexual developmental pathways are not clear.18 It can 
therefore be difficult to know which CYP referred to GIDS 
are more likely to access medical treatment (hormone 
blockers to suppress puberty or cross sex hormones). In 
addition, factors that may be associated with the likeli-
hood of receiving such treatment and the physical and 
psychological impacts of receiving this treatment have 
not yet been fully ascertained.21 Identifying these factors 
should provide much needed evidence to inform the care 
of gender diverse CYP attending services.
There is also limited research on the direct healthcare 
costs and indirect wider societal costs for CYP referred 
to gender services and this information is important for 
policy makers and service providers to consider when 
planning services. In the context of a finite health budget, 
reporting this information alongside health and quality 
of life gains provides information on the potential value 
for money of gender services and how they might best 
be configured for maximum benefit to the healthcare 
service and wider society.
In summary, this study aims to improve understanding 
of the outcomes of CYP referred to the UK GIDS, specif-
ically regarding gender identity, mental health, physical 
health and quality of life. The impact of factors such 
as co- occurring autism and early social transition on 
outcomes over time will be explored. The UK GIDS is 
one of the largest specialist gender services for CYP in 
the world and is therefore an ideal service from which 
to recruit. This is the first longitudinal study to assess 
outcomes of CYP referred to gender services in the UK 
and is novel in terms of recruiting families who are on 
the waitlist for the GIDS at baseline, the inclusion of a 
cohort of CYP who were ≤14 years at the time of referral 
and the commitment to follow- up over time, regardless of 
whether families actually attend the service.
Aims
This study aims to investigate the outcomes of CYP 
referred to the UK GIDS and the factors that are asso-
ciated with these outcomes. Specifically, the study aims 
to establish: (1) the proportion of CYP who experience 
ongoing gender dysphoria and access medical treat-
ment; (2) factors that are associated with ongoing gender 
dysphoria and treatment choice; and (3) how (A) medical 
treatment, (B) social transition and (C) co- occurring 
autism impact physical health, well- being, quality of life, 
peer and family relationships and cost to the National 
Health Service (NHS) and other public services.
METHODS AND ANALYSIS
Study design
A prospective longitudinal cohort study examining the 
outcomes of CYP referred to the UK GIDS. This study 
forms part of a wider programme of research investigating 
Longitudinal Outcomes of Gender Identity in Children 
(the LOGIC study).22 This programme of research uses a 
mixed methods approach, incorporating both quantita-
tive and qualitative longitudinal studies to investigate the 
experiences, outcomes and well- being of families referred 
to the UK GIDS. Please see the LOGIC- Q protocol for 
details on the longitudinal qualitative study, which 
involves semistructured interviews with a purposively 
sampled subset of up to 40 families who have completed 
the quantitative assessments (McKay et al, under review).
Study setting
The study is based at the Tavistock & Portman NHS Foun-
dation Trust and is recruiting participants from the GIDS 
waitlist. The GIDS is a nationally commissioned service 
covering England, Wales, Northern Ireland and in part, 
Scotland and the Republic of Ireland, through a series 
of outreach clinics and main hubs in London and Leeds. 
The study start date was July 2019, and the anticipated 
end date is May 2023.
Participants and eligibility
Participants will consist of CYP aged 3–14 years at the time 
their referral to the GIDS was accepted and their parent/
caregiver. Referrals can be made by Child and Adolescent 
Mental Health Services, or from other health, social care 
or educational professionals, including GPs. The service 
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does not accept self- referrals from CYP or their families. 
In order for the referral to be accepted, the referral must 
indicate that the CYP is experiencing concerns or distress 
around their gender identity. Inclusion criteria for CYP 
are: had a referral to the GIDS accepted; awaiting first 
appointment with the service when baseline measures are 
completed; speak English; live in the UK or the Republic 
of Ireland. Families will still be eligible to participate in 
the study even if, after referral, they no longer wish to 
remain on the waitlist for an appointment with the GIDS. 
Exclusion criteria for CYP are: aged >14 years at the time 
their referral to the GIDS was accepted; already attended 
an appointment at the GIDS before baseline measures 
are completed; do not provide assent to take part; and do 
not have parent/caregiver consent. Parents/caregivers of 
eligible CYP will be asked to provide informed consent 
in order to participate and must also be proficient in 
English and live within the UK or the Republic of Ireland.
Recruitment and consent
Potential participants will be identified from referrals 
received by the GIDS, and recruitment will consist of a 
three- step process. Potential participants (CYP and their 
families) will receive a study invitation letter informing 
them of the study and inviting them to take part. At least 
three working days after the letter is sent, the family will 
be contacted by telephone by a member of the GIDS 
administrative team. The purpose of this telephone call 
is to highlight the study to potential participants and seek 
their consent to pass their contact details to the LOGIC 
research team. If potential participants agree for their 
contact details to be passed on, a researcher from the 
LOGIC research team will then contact them directly 
and provide them with information sheets, including an 
age- appropriate version for the CYP. Families will have 
the opportunity to discuss the study with the researcher, 
and if they are happy to participate, arrangements will be 
made for completion of the baseline measures.
Informed consent will be requested from all parents/
caregivers at baseline prior to completion of the assess-
ment measures. All CYP will be asked to assent at base-
line and follow- up time points. Consent will be requested 
and recorded on either a paper or online consent form, 
depending on how the measures are completed. Partic-
ipants will be informed that their decision to partici-
pate in the study (or not) will have no impact on their 
access to care, their position on the referral waiting list 
or their future care pathway. Any clinical care team that 
the participant may go on to have will not know that the 
individual is taking part in the study unless they choose 
to share that information with them. Participation in the 
study will not be routinely documented on the partic-
ipant’s medical record. The only exception to this is if 
risk is identified for the child or young person, in which 
case the research team will follow a risk protocol that may 
result in a referral to the GIDS enquiries line to initiate 
support for the family. This information would be docu-
mented on the individual’s medical record, but referrals 
such as this will only be made with the parent/caregiv-
er’s consent. Participants will be informed that they have 
the right to withdraw from the study at any time, without 
providing a reason and without any impact on their access 
to care or their care pathway.
Data collection and measures
Data will be collected from both the CYP and their parent/
caregiver. However, in some circumstances (eg, CYP does 
not wish to participate), data may only be collected from 
a parent/caregiver. Depending on the age of the CYP 
and participant preference, assessments will be carried 
out either in a face- to- face, video call or telephone inter-
view format with a research assistant (this method will 
primarily be used with children <12 years and/or those 
with neurodevelopmental conditions) or via a self- report 
questionnaire in a paper or electronic format (via Qual-
trics, an online survey platform). It is anticipated that the 
majority of participants aged ≥12 years and their parent/
caregiver will complete the questionnaires online via 
the Qualtrics survey platform. In the event that a partici-
pant becomes distressed or discloses a risk/safeguarding 
concern during an assessment, the researchers will adhere 
to the study risk protocol.
Questionnaires and assessments will include measures 
of: gender dysphoria and gender identity; social transi-
tion; mental health and well- being; autistic traits; self- 
evaluation of puberty stage, height and weight; quality 
of life; peer and family relationships; sociocultural and 
demographic factors; and healthcare and societal costs. 
Measures will be completed at baseline and 1- year and 
2- year follow- up periods. For a detailed list of measures, 
please see table 1.
For participants who are referred to and attend an endo-
crinology clinic at University College London Hospitals 
NHS Foundation Trust or Leeds Teaching Hospitals NHS 
Trust, access to routinely collected clinical measurements 
of body composition, bone density and age and blood 
test values will be requested. Participants will be given 
the option to consent to the research team accessing this 
information, and therefore, requests will only be made 
for participants who provide consent. Clinicians and/
or endocrinologists will not know who is taking part in 
the study or for which participants this information is 
requested. These data will be collected by a member of 
the LOGIC research team with assistance from a research 
nurse at each site. As per current NHS treatment proto-
cols, those receiving medical treatment with hormone 
blockers (gonadotropin- releasing hormone agonists 
(GnRHa)) and/or cross- sex hormones will be monitored 
for changes in blood count, renal and liver function, 
skeletal maturity and bone density and Tanner pubertal 
staging. These data will allow adult height predictions to 
be tracked and clinical measurements of body propor-
tions, height, spinal height, shoulder and hip widths 
and body composition by bioelectrical impedance to be 
taken. For a list of these clinic derived variables, please 
see table 2.
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Table 1 Summary of assessment measures to be completed at each time point
Measure Data collected
Informant/
source Baseline 12 months 24 months
Demographics/
background
Caregiver: age, gender, education, occupation, 
sexual orientation, ethnicity and relationship to 
child.
CYP: age, sex assigned at birth, ethnicity, age at 
referral and background to referral.
P × × ×
Gender identity
Parent Questionnaire DSM-5 criteria for gender dysphoria in child; 
family experiences of child’s gender identity; 
gender expression and social transition; and 
body image and body distress.
P × × ×
Child Semi- Structured 
Interview
Verbal identification with experienced gender; 
gender expression and social transition; age 
first realised and expressed gender identity; and 
body image and distress.
C × × ×
Young Person 
Questionnaire
DSM-5 criteria for gender dysphoria; distress 
around gender identity; gender expression and 
social transition; body image and body distress; 
and sexual orientation.
YP × × ×
Gender Similarity 
Task28
Perceived similarity to own- gender and other- 
gender peers.
C × × ×
Gender Diversity 
Questionnaire7
Verbal identification with expressed gender; 
gender fluidity; gender expression; age first 
realised and expressed gender identity.
YP × × ×
Utrecht Gender 
Dysphoria Scale29
Severity of gender dysphoria. YP × × ×
Gender Identity Self 
Stigma Scale30




Emotional reactivity; anxious/depressed; 
somatic complaints; withdrawn; sleep problems; 
attention problems; and aggressive behaviour.
P × × ×




Emotional symptoms; conduct problems; 
hyperactivity/inattention; peer relationship 
problems; and prosocial behaviour.
P and YP × × ×
Youth Self Report31 Anxious- depressed; withdrawn/depressed; 
somatic complaints; social problems; thought 
problems; attention problems; rule- breaking 
behaviour; and aggressive behaviour.
YP × × ×
Moods and Feelings 
Questionnaire34
Depressive symptoms in child or adolescent. YP × × ×
Warwick- Edinburgh 
Mental Well- being 
Scale35
Mental well- being. YP × × ×
Child and Youth 
Resilience Measure36
Brief screener for resilience processes in the 
lives of children and adolescents.
C and YP × × ×
Healthcare resource 
use
Child & Adolescent 
Service Use 
Schedule37
All- cause uses of hospital, community- based 
and private health and social care services.
P × × ×
Quality of life
Continued




source Baseline 12 months 24 months
Kidscreen-5238 Physical well- being, psychological well- 
being, moods and emotions, self- perception, 
autonomy, parent relations and home life, social 
support and peers, school environment, social 
acceptance (bullying), and financial resources.
P or C, YP × × ×
Child Health Utility 9 
Dimensions39
Paediatric health- related quality of life for use in 
economic evaluation (quality adjusted life years).
P or C, YP × × ×
Physical measures
Parental height Height in centimetres. P ×
CYP pubertal 
development
Tanner stage. P and YP × × ×
CYP height, weight, 
BMI
Height in centimetres; weight in kilograms. P and YP × × ×
Child (C) ages for data collection are 3–11 years. Young people (YP) ages for data collection are ≥12 years. Parental (P) proxy measures are 
available for children (aged <8 years) not able to self- complete quality of life instruments.
BMI, body mass index; CYP, children and young people.
Table 1 Continued
Table 2 Endocrinology clinic derived measurements for young people receiving medical treatment
Data source Initial assessment
Follow- up (FU) 
3–6 months on 
GnRHa
Follow- up (FU) 12 




Height, sitting height, 
biacromial width, bi- iliac 
width and weight
Clinical measures × × ×
BMI Value derived by calculation × × ×
Parent’s height Clinical measure ×







Bone densitometry Dexa scan × × ×
Bone age X- ray of left hand and wrist × × ×
General blood measures
Full blood count, ferritin (iron) Blood test × × ×
Renal, liver, lipid and bone 
profiles
Blood test × × ×
Vitamin D Blood test × × ×
Endocrine measures
Thyroid function test Blood test × × ×
Reproductive hormones: 
FSH, LH, PRL, testosterone, 
oestradiol
Blood test × × ×
BMI, body mass index; FSH, follicle stimulating hormone; GnRHa, gonadotropin- releasing hormone agonists; LH, luteinising hormone; PRL, 
prolactin.
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Personal data provided by potential participants during 
the recruitment phase, prior to assessments, will be held 
in a password- protected database on an encrypted NHS 
server at the Tavistock and Portman NHS Foundation 
Trust, accessible solely to the chief investigator and imme-
diate research team. Pseudonyms, in the form of partic-
ipant ID numbers, will be assigned to participants once 
they have agreed to complete the baseline measures. 
Participant ID numbers will be held in a password- 
protected database on an encrypted NHS server at the 
Tavistock and Portman NHS Foundation Trust.
Sample size
It is estimated that 638 participants will be recruited over 
an 18- month period assuming a recruitment rate of 70% of 
all eligible referrals of CYP to the GIDS. Allowing for 20% 
attrition, the final sample size with complete follow- up 
data is expected to be 510 participants. Assuming the 
proportion of CYP with gender dysphoria to be 40%, a 
sample size of 510 (number of GD events=204) will allow 
us to estimate 20 regression coefficients with adequate 
precision using a logistic regression model, based on 
prespecified explanatory variables.23 This sample size 
is more than sufficient to investigate the association 
between these explanatory variables and other contin-
uous clinical outcomes using a linear regression model.24 
For the analysis of the binary gender dysphoria outcome, 
if we are unable to obtain complete follow- up data from 
510 participants, we will limit the number of explanatory 
variables that will be included in the multivariable regres-
sion model. This decision will be based on the clinical 
importance/relevance of the variables, and this will be 
prespecified in the statistical analysis plan.
During baseline recruitment, as our initial target of 
recruiting 70% of incoming referrals of CYP aged ≤13 
years was not being achieved, our recruitment strategy 
was reviewed, and the decision was made to also recruit 
families on the existing GIDS waitlist and to increase 
the eligibility criteria to those aged ≤14 years when their 
referral to the GIDS was accepted. The families of all CYP 
who meet the eligibility criteria will be invited to partici-
pate in the study.
Analysis plan
Data will be analysed in STATA by the statistical team at 
UCL PRIMENT’s Clinical Trials Unit. Pseudonymised 
datasets will be sent to the team via University College 
London’s (UCL) General Data Protection Regulation 
(GDPR) compliant Data Safe Haven file transfer portal. 
Participant characteristics at baseline and outcomes 
will be presented using mean (SD), median (IQR) or 
frequencies (proportion), as appropriate. Characteris-
tics and outcomes of participants who drop out of the 
study will be described and compared descriptively to 
those with complete follow- up data in order to establish 
whether there are differences between these participants 
or factors that may have motivated them to leave the study.
A logistic regression model will be used to explore 
associations between the prespecified explanatory vari-
ables and the binary gender dysphoria outcome. Linear 
regression models will be used for the continuous 
clinical outcomes. Appropriate regression models will 
be used to investigate explanatory variables for other 
outcomes. Models that account for repeated measure-
ment data will be used where appropriate, including 
time period as an additional covariate. Model assump-
tions regarding linear relationships and normality for 
continuous variables will be investigated. Any violation 
of these assumptions will be handled using appropriate 
statistical methods. Exploratory subgroup analyses will 
be carried out for prepubertal children and CYP with 
autistic traits using descriptive statistics and appropriate 
regression models, where possible. Physical health, 
well- being and quality of life outcomes over time will 
be compared descriptively between those in receipt of 
hormone blockers (GnRHa) and those of a similar age/
pubertal stage who progress through puberty without 
such intervention. Physical health data routinely 
collected by the endocrine service (see table 2) will be 
reported descriptively.
Resource use will be collected using the child and 
adolescent services use schedule (CA- SUS), which has 
been specifically adapted for this study. The CA- SUS 
collects information about service use in the past 6 
months regarding heath care resource use, including: 
GIDS, private, primary and secondary care, mental 
health, school attendance, educational support, volun-
tary services and medication. Reponses to the CA- SUS 
will be costed using the Personal Social Services Resource 
Unit,25 NHS reference costs,26 British National Formu-
lary27 and other published sources. Descriptive statis-
tics for resource use and cost (numbers, percentages, 
means and SD per CYP) will be reported by CYP in active 
contact with the service versus those who are not. Further 
subgroup analyses will explore resource use and cost by 
medical treatment, social transition, co- occurring autistic 
traits and prepubertal children. Key predictors of costs 
will be investigated by including prespecified explanatory 
variables and ‘active contact with GIDS’ in appropriate 
general linear models (GLMs). The most appropriate 
GLM will be chosen using the Akaike information 
criteria. This will allow additional cost or cost- savings 
associated with active GIDS contact to be estimated. 
Similar models will also be used to investigate whether 
active contact with GIDS is related to improvements in 
quality of life. This will be based on quality- adjusted life 
years calculated using the CHU9D, the relevant tariff and 
the area under the curve.
Bias in relation to missing data will be investigated. 
If required, logistic regression will be used to identify 
predictors of missingness, and these predictors will be 
included in the analysis models as part of secondary 
analyses. Multiple imputation may be used to impute the 
missing values of the explanatory variables, if appropriate.
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Data storage
All data will be held in a password- protected database on 
an encrypted NHS server at the Tavistock and Portman 
NHS Foundation Trust. Data processing agreements 
and data sharing agreements are in place between the 
Tavistock & Portman NHS Foundation Trust and study 
collaborators. Data transferred to UCL for analysis will be 
retained in a GDPR- compliant Data Safe Haven, which is 
security key and password- protected.
Patient and public involvement
The LOGIC study was developed in collaboration with a 
service user coapplicant and coauthor (TW), UK GIDS 
users and external stakeholders. CYP and their fami-
lies using the UK GIDS were consulted regarding their 
priorities for research at GID Service User Family Days in 
London and Leeds. This informed the research proposal 
and application for funding, which was shared and further 
reviewed with three parents of young people accessing 
the service. Throughout the study, the research team will 
host CYP and parent/caregiver advisory groups who will 
meet every 6 months to provide ongoing feedback and 
advice on the study. These will include families who are 
participating in the LOGIC study.
ETHICS AND DISSEMINATION
This study has been approved by the Health Research 
Authority and London – Hampstead Research Ethics 
Committee (Reference: 19/LO/0857). The study find-
ings will be published in peer- reviewed journals and 
presented at both conferences and stakeholder events. 
No identifiable data will feature in the dissemination of 
results. It is hoped that the findings will be used to inform 
clinical practice in the NHS and elsewhere.
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